Clinical Trials Directory

Trials / Completed

CompletedNCT02434653

A Comparison Between Two Strategies for Postpartum Anemia Diagnosis and Follow up After Vaginal Deliveries

A Comparison Between Two Strategies for Postpartum Anemia Diagnosis and Follow up After Vaginal Deliveries - Hemoglobin Screening in High Risk Population Versus by Symptoms

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,679 (actual)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Anemia diagnosis by hemoglobin level monitoring in women after vaginal delivery by symptoms versus screening of women at increased risk for post-partum anemia.

Detailed description

Anemia is common following delivery. It is associated with some serious complications including increased risk for syncope and in severe cases even cardiogenic shock. Yet, anemia-associated symptoms might manifest relatively late after the patient have lost a fair amount of blood, which was not diagnosed early enough. To date, there are not acceptable guidelines for monitoring hemoglobin levels after delivery. Theoretically, there are 2 approaches for hemoglobin monitoring - one by taking hemoglobin levels in order to diagnose anemia in patients reporting anemia-associated symptoms. The other approach is by screening of women at increased risk for post-partum anemia. In the present study we aimed to compare those 2 approaches.

Conditions

Interventions

TypeNameDescription
OTHERMonitoring hemoglobin levels following anemia associated symptomsPost-partum anemia will be diagnosed after vaginal delivery by taking hemoglobin levels to patients with symptoms consistent with anemia, severe postpartum hemorrhage or hemoglobin level below 8 g/dL.
OTHERMonitoring hemoglobin levels to detect anemia by screening of women at increased risk for post partum anemiaPost-partum anemia will be diagnosed after vaginal delivery by taking hemoglobin levels to high risk women for post-partum anemia, defined as hemoglobin levels of 10.5 g/dl or below around delivery, or severe postpartum hemorrhage with or without symptoms associated with anemia

Timeline

Start date
2015-06-01
Primary completion
2017-05-01
Completion
2017-05-01
First posted
2015-05-05
Last updated
2017-07-14

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02434653. Inclusion in this directory is not an endorsement.